Available online at www.sciencedirect.com

Bioorganic & Medicinal Chemistry Letters 18 (2008) 2229

Corrigendum

Corrigendum to ``Design and synthesis of potent amidoand benzyl-substituted cis-3-amino-4-(2cyanopyrrolidide)pyrrolidinyl DPP-IV inhibitors'' [Bioorg. Med. Chem. Lett. 17 (2007) 6707­6713]
J. W. Corbett,* K. Dirico, W. Song, B. P. Boscoe, S. D. Doran, D. Boyer, X. Qiu, M. Ammirati, M. A. VanVolkenburg, R. K. McPherson, J. C. Parker and E. D. Cox
Pfizer Global Research and Development, Eastern Point Road, Groton, CT 06340, USA
Available online 7 February 2008

The authors regret that the structure of alogliptin was incorrectly drawn. The correct structure is shown here.
O N H2N N N CH3 O

NC

DOI of original article: 10.1016/j.bmcl.2007.10.063 * Corresponding author. Tel.: +1 860 686 0252; e-mail: jeffrey.w.corbett@pfizer.com 0960-894X/$ - see front matter Ó 2008 Published by Elsevier Ltd. doi:10.1016/j.bmcl.2008.02.003

